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Abstract
Oxcarbazepine (OXC) has attracted much attention owing to its multiple health benefits. OXC is an anticonvulsant 
and mood stabilizing drug, used primarily in the treatment of epilepsy. This study developed and validated a simple, 
specific, sensitive and reliable stability indicating UV-Spectrophotometric method for the quantitative determination 
of oxcrbazepine in pure and in pharmaceutical dosage forms. Analysis was performed using methanol: aceonitrile 
(50:50) as diluents. UV detection was performed at 254 nm. The calibration plot was linear over a concentration 
range of 0.0-15 µg ml-1 with correlation coefficient values >0.9986. The method was validated for specificity, linearity, 
precision, accuracy, limit of detection, limit of quantification and robustness. The forced degradation studies were 
performed by using HCl, NaOH, H2O2, thermal and UV radiation. Oxcarbazepine is more sensitive towards alkaline 
conditions and very much resistant towards acidic, oxidative and photolytic degradations. The method was validated 
as per ICH guidelines. The RSD for intra- and inter-day precision were found to be lesser than 3%. The percentage 
recovery was in good agreement with the labeled amount in the pharmaceutical formulations and the method is 
simple, specific, precise and accurate for the determination of oxcarbazepine in pharmaceutical formulations
Keywords: Oxcarbazepine; UV-Spectrophotometry; Pharmaceuti-
cal preparations; Stress studies
Introduction
UV-Vis Spectrophotometer (UV) is long-used analytical equipment 
with property of high sensitivity and selectivity. It can be widely used 
in pharmaceutical, biochemical, food, life-science industries for R&D, 
quality assurance and other applications. 
Oxcrabazepine (OXC) is chemically known as, 10,11-dihydro-10-
oxo-5H-dibenz (b,f) azepine-5-carboxamide (Figure 1). OXC, is a keto 
analog of carbamazepine and is an anticonvulsant and mood stabilizing 
drug. OXC is known to exert antiepileptic activity by blockade of 
voltage–dependent sodium channels in the brain. It protects mice and 
rats against generalized tonic-clonic seizures induced by electroshock 
which is thought to act via inhibition of sodium channel activity. It is 
commercially available under trade names, Oxrate (Wockhard), Oxetol 
(Sun Pharma), Oxcarb (Cipla) etc. The drug is not yet official in any 
pharmacopoeias.
OXC is used to treat seizures, several types of epilepsy and in 
management of intractable trigeminal neuralgia. In treatment of 
epilepsy, oxcarbazepine has recently been found to be associated with 
a greater enhancement in mood and reduction in anxiety symptoms 
than other drugs employed to treat epilepsy [1]. Oxcarbazepine is a 
prodrug which is activated to eslicarbazepine in the liver [2].
To date, all analytical methods described in literature for the 
determination of OXC in pharmaceuticals or in biological and other 
matrices involve voltammetry [3], chiral liquid chromatography 
method with ultraviolet detection (LC-UV) [4,5], micellar 
electrokinetic chromatography [6], microemulsion electrokinetic 
chromatography [7], HPLC [8-20], capillary electrophoresis [21], GC-
MS [22] and spectrophotometry [23-29]. The reported methods in 
the literature suffer from one or the other disadvantage such as poor 
sensitivity [23-26,28], scrupulous control of experimental variables, 
time consuming [27,29], costly reagents [26,29] and uses heating 
steps [29]. Since, very few methods are reported in the literature and 
no stability indicating method is available in the official compendia 
using UV-Spectrophotometry for analyzing of OXC in dosage forms. 
Hence there is a need to develop a simple, rapid, accurate and precise 
spectrophotometric method for the determination of OXC in tablets 
as an alternative method to stability indicating HPLC methods. 
Comparison of the performance characteristics of the existing visible 
spectrophotometric methods with the proposed method is shown in 
Table 1.
The presented work is aimed at the development and validation 
of a new analytical method for determination of the anticonvulsant 
drug oxcarbazepine according to the current ICH guidelines [30]. A 
N
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Figure 1: Structure of oxcarbazepine.
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burette and the volume was made up to the mark with acetonitrile. 
Absorbance of each solution was measured at 254 nm against 
acetonitrile, (blank). Calibration curve was prepared by plotting 
absorbance vs. concentration of drug. Concentration of unknown was 
read from the concurrent calibration curve or the regression equation 
using Beer’s law data.
Procedure for tablets: For analysis of the tablet dosage forms, 
twenty tablets from each brand (Oxrate, Oxetol and Mezalog tablets) 
were ground into fine powder and quantity of the powder equivalent 
to 10 mg of OXC was weighed accurately into a three separate 100 ml 
calibrated flasks and 50 ml of methanol was added. The content was 
shaken for about 30 min; the volume was diluted to the mark with 
acetonitrile and mixed well and filtered using a Whattman no.41 filter 
paper. The filtrate containing OXC was at a concentration 100 µg 
ml-1 was subjected to analysis by the procedure described above after 
suitable dilution step.
Analysis of placebo blank: A placebo blank containing starch 10 
mg, methyl cellulose 15 mg, gum acacia 20 mg, talc 15 mg, magnesium 
stearate 15 mg and sodium alginate 10 mg was prepared by combining 
all these components to form a homogenous mixture. 10 mg of 
placebo blank was accurately weighed and its solution was prepared as 
described under “Procedure for tablets”, and then subjected to analysis 
as described under procedure for the “Preparation of calibration curve”.
Analysis of synthetic mixture: To the placebo blank of the 
composition described above, 10 mg OXC was added into a 100 ml 
calibrated flask and homogenized, and the solution was prepared as 
described under “Procedure for tablets”, and then subjected to analysis 
by the procedure described under “Preparation of calibration curve”. 
The analysis was used to study the interferences of excipients such as 
talc, acacia, starch, methyl cellulose, sodium citrate, sodium alginate 
and magnesium stearate.
Forced degradation studies: Forced degradation studies were 
thorough literature survey reveals that, there is no method available 
for the quantitative determination of oxcarbazepine in pure and in 
pharmaceuticals by UV-Spectrophotomtric (stability indicating) 
technique using methanol: aceonitrile. Hence, the author has presented 
a simple, highly sensitive and cost-effective spectrophotometric 
technique using methanol: aceonitrile as diluents.
Experimental
Apparatus
Spectrophotometric analysis for the study of spectral and 
absorbance measurements was carried out on a Systronics model 118 
UV-Vis Spectrophotometer provided with 1 cm matched quartz cells.
Reagents and standards 
All chemicals and reagents used were of analytical reagent grade 
and HPLC grade acetonitrile and methanol was purchased from Merck 
(Mumbai, India).
Preparation of standard OXC solution: Pharmaceutical grade 
OXC certified to be 99.99% pure was received from Cipla India Ltd., 
Mumbai, India, as a gift and was used as received. A stock standard 
solution equivalent to 100 µg ml-1 of OXC was prepared by dissolving 
10 mg of the pure drug in 50 ml methanol and diluted to 100 ml with 
acetonitrile. Working solutions were prepared as required by dilution.
Pharmaceutical formulations of oxcarbazepine such as Oxrate 150 
mg, (Wockhard), Oxetol 150 mg (Sun Pharma) and Mezalog 150 mg 
(La Pharma) were purchased from local markets.
General procedures
Preparation of calibration curve: Aliquots of standard solution 
containing 0.0, 0.25, 0.5, 1.0, 2.5, ………..7.5 ml (20 µg ml-1) of OXC 
were transferred into a series of 10 ml calibrated flasks using micro 
Sl. No. Reagent/s used Methodology Linear range, µg ml-1 and molar 
absorptivity, l mol-1 cm-1
Remarks References
1 The absorbance of green colored chromogen 
was measured at 770 nm
4-28 µg ml-1
(€ = 4.63 × 103)
Less sensitive [23]
2 Anthranilic acid and 
2-chlorophenylhydrazine
Colored condensation product showed 
absorption maximum at 485 nm
- Less sensitive [24]
3 Folin-Ciocalteu phenol reagent (FCP)
 
The absorbance of the intense blue color of the 
reduced FCP was measured at 760 nm
OXC undergoes oxidative coupling with MBTH 
to form 
5-30
(€ = 8.06 × 103)
10.0-50
Less sensitive
Less sensitive
[25]
4 3-methyl-
2-benzothiazolinone hydrazine
hydrochloride (MBTH)
green colored chromogen, measured at 456 
nm
(€ = 3.126 × 103) Less sensitive 
and the use of  
costly reagent 
[26 ]
5 N-bromosuccinimide (NBS) and 
bromopyrogallol red (BPR) as reagents
The absorbance of the unreacted BPR was 
measured at  460 nm
0.8-8
(€ = 2.52 × 104)
The reagent is 
not stable and 
requires 
30 min for color 
development
[27]
6 Methanol (method A)
and acetonitrile (method B)
Shows maximum absorbance at 254 nm
--same---
2-40 Less sensitive [28]
7 Use of Cerium(IV) and leuco dyes as 
reagents (Proposed methods)
The absorbance of crystal violet was measured 
at 580 nm (method A),
bluish-green
colored malachite green at 610 nm (method 
B) and
blue color of xylene cyanol FF at 610 nm 
(method C)
0.0-2.5
(€ = 3.86 × 104)
0.0-2.0
(€ = 4.41 × 104)
0.0-2.5
(€ = 2.16 × 104)
Sensitive but 
requires heating 
[29]
8 Methanol:aceonitrile UV-spectrophotometry 0.0-15 Highly sensitive Developed 
method
Table 1: Comparison of the performance characteristics of the existing visible spectrophotometric methods with the proposed method.
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carried out for OXC to provide an indication of the stability indicating 
property and specificity of proposed method. Forced degradation 
of drug substances was carried out under acidic, basic, oxidative, 
photolytic and thermal stress conditions. 
Acid and base decomposition: Solutions for acid and alkaline 
degradation studies were prepared by taking 2.5 ml of 20 μg ml-1 
OXC separately in two 10 ml calibrated flasks and mixed with 1 M 
hydrochloric acid (acid hydrolysis) and 0.1 M NaOH (base hydrolysis), 
respectively. All the solutions were stored at 80°C for 8 h. Then, the 
solution was cooled to room temperature and diluted to the mark with 
acetonitrile, and the absorption spectra of the resulting solutions were 
recorded.
Oxidation studies: Oxidative degradation study was performed 
using hydrogen peroxide solution at room temperature. Solution for 
use in oxidation studies was prepared by taking 2.5 ml (20 μg ml-1) OXC 
in a 10 ml calibrated flask and mixed with 5% H2O2. Then, the solution 
was kept at room temperature for 8 h and diluted to the mark with 
acetonitrile, and the absorption spectra of the resulting solutions were 
recorded.
Photolytic degradation: Photo degradation studies were carried 
out by exposing the drug solution (20 µg ml-1) as well as powder drug 
in a photo stability chamber for 3 days. The powder was spread as a thin 
layer in a petri plate. The samples of both solution and powder were 
kept in parallel in darkness (wrapped) for the same period.
Thermal degradation studies: To investigate the susceptibility of 
the drug under thermal stress conditions, the drug was spread in a 
borosilicate glass petri-dish and placed in the hot-air oven maintained 
at 80°C for 8 h and after cooling to room temperature, 1 mg of OXC 
was weighed and transferred to a 100 ml calibrated flask, dissolved 
in acetonitrile and diluted up to the mark with the same solvent. The 
absorption spectrum was recorded from 230-400 nm.
Results and Discussion
Absorption spectra
Attempt has been made to develop a rapid, highly sensitive, precise 
and accurate analytical method for oxcarbazepine in pure and in 
dosage forms. The proposed UV method allows rapid and eco nomical 
quantitation of OXC in tablets without any time-consuming sample 
preparation. Moreover, the spec trophotometric method involves 
simple instrumentation compared with other instrumental techniques. 
Further, OXC stock solutions and working standards were made 
in methanol:acetonitrile (50:50, v/v) and acetonitrile, respectively. 
It showed maximum absorption maximum at 254 nm, and at this 
wavelength acetonitrile (blank), had no significant absorbance. The 
absorption spectrum of OXC is presented in Figure 2.
Results of forced degradation
The ICH guideline provides useful definitions and general comments 
about forced degradation studies. Stress testing provides evidence on 
how the quality of a drug may be affected under the influence of different 
stress conditions. The degradation products can cause changing of 
chemical, pharmacological and toxicological properties of drugs having 
significant impact on product quality and safety [31]. The OXC sample 
in acidic, oxidative (5% H2O2) and thermal hydrolysis showed 1.27, 2.54 
and 1.01% degradation, respectively. The photolytic degradation was not 
observed when OXC was exposed in solid state to UV light for 3 days. 
The drug was found to be more stable to acidic hydrolysis as compared 
to alkaline hydrolysis. Major degradation up to 15.73% occurred under 
alkaline conditions. Therefore, it may be concluded that OXC is more 
susceptible to alkaline, less susceptible to acidic and oxidative and stable 
towards thermal and photolytyic conditions. Percent degradation was 
calculated by comparing the absorbance values of the drug degraded in 
each degradation condition with the corresponding absorbance values 
of the drug under non-degradation condition. Based on the previous 
report [32,33], the absorption spectrum (Figures 3a-c) obtained under 
basic, oxidative and acidic conditions shows degradation of OXC, 
whereas the absorption spectrum obtained under photolytic and 
thermal conditions shows no or negligible degradation of OXC and the 
summary of forced degradation results are shown in Table 2.
Method validation
The method developed was validated as per ICH/USP guidelines 
for parameters like linearity and sensitivity, limits of detection (LOD) 
and quantitation (LOQ), precision, accuracy, ruggedness, selectivity 
and recovery.
Linearity, sensitivity, limits of detection and quantitation: 
Linearity is usually expressed in terms of the variance around the 
slope of regression line, and is calculated according to an established 
mathematical relationship from test results obtained by the analysis of 
samples with varying concentrations of analyte. Under the established 
experimental conditions, a linear correlation was found between the 
absorbance at respective wavelengths and concentration of OXC in the 
ranges is given in Table 3. Regression analysis of the calibration curve 
(Figure 4) using the method of least-squares was made to calculate the 
slope (b), intercept (a) and correlation co-efficient (r) and the values 
are presented in Table 3. The optical characteristics such as absorption 
maxima, Beer’s law limit, molar absorptivity and Sandell’s sensitivity 
values [34] are also given in Table 3. 
The limit of detection (LOD) and limit of quantification (LOQ) 
evaluated as per ICH guidelines using the formulas:
3.3×LOD=
s
σ
10×LOQ=
s
σ
   Figure 2: Absorption spectrum for OXC (5 µg ml-1).
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Degradation condition Time * Drug decomposed (%) * % of drug remaining after degradation Remarks
HCl 1 M at 80 °C 8 h 1.27 98.73 Negligible degradation 
NaOH 0.1 M at 80 °C 8 h 15.73 84.27 Degradation
Oxidation by H2O2
 (5 %), at room temp. 
8 h 2.54 97.46 less degradation
Thermal solid, 80 ºC 8 h 1.01 98.99 No degradation
UV 3days 0.97 99.03 No degradation
*Mean value of three replicates
Table 2: Summary of forced degradation results.
Table 3: Analytical and regression parameters of the proposed method.
Parameter Method 
λmax nm 254
Beer’s law range (µg ml-1) 0.0 - 15
Linear range (µg ml-1) 0 .5 – 12.5
Molar absorptivity (ε), (l mol-1cm-1) 1.34 x 104
Sandell sensitivity (µg cm-2) 0.0188
Intercept (a) 0.0147
Slope (b) 0.0458
Correlation coefficient (r) 0.9986
LOQ (µg ml-1) 0.1667
LOD (µg ml-1) 0.0550
*y=a+bx, where x is the concentration of OXC in μg ml-1 and y is the absorbance at 254 nm; Sa is the standard deviation of the intercept, Sb is the standard deviation of 
the slope.
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Figure 3 (a): Acid degradation,  (b): Base degradation (c): Oxidative degradation.
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OXC taken, µg ml-1
Intra-day accuracy and precision Inter-day accuracy and precision
OXC found*,µg 
ml-1 RE, %  RSD, %
OXC found**,µg 
ml-1 RE, %  RSD, %  
Proposed Method 
2.5 2.48 0.67 1.03 2.51 -0.55 1.37
7.5 7.45 0.71 1.34 7.56 -0.74 1.09
12.5 12.38 0.96 0.88 12.60 -0.83 2.56
RE: Relative error; RSD: Relative standard deviation; 
* Mean value of 5 determinations
** Mean value of 3 determinations
Table 4: Evaluation of accuracy and precision.
OXC taken, µg ml-1
Ruggedness
Inter-analysts (% RSD), n=3 Inter-instruments (% RSD), n=3
Proposed Method
2.5 1.95 2.10
7.5 1.64 1.76
12.5 1.79 1.99
Table 5: Method Ruggedness expressed as intermediate precision (% RSD).
Where σ is the standard deviation (n=5) of reagent blank 
determination and s is the slope of the calibration curve.
Precision and accuracy: The intra-day and inter-day precision and 
accuracy of the proposed method was established by replicate analysis 
of OXC samples at three different concentrations (low, medium and 
high) (Table 4) within the working limits, each being repeated five times. 
The relative error, RE (%) and relative standard deviation, RSD (%) 
values of both intra and inter-day studies were satisfactory and showed 
that the best appraisal of the procedures in daily use. The analytical 
results obtained from this investigation are summarized in Table 4. The 
values percentage relative error between the concentrations of OXC for 
taken and found showed the high accuracy of the method. The results 
obtained are presented in Tables 4 and 5 and show that the accuracy 
is good.
Application to analysis of pharmaceutical samples: The method 
was applied successfully to the determination of OXC in dosage forms. 
To check the validity of the proposed method, OXC was determined in 
Oxrate, Oxetoland Mezalogtablets and the results are presented in Table 
6. The results of an assay were statistically compared with the reference 
method [28] by applying the Student’s t- test for accuracy and F- test for 
precision. The results in the Table 6 showed that there is no significant 
difference between the proposed and the reference method at the 95% 
confidence level with respect to accuracy and precision. The calculated 
t- and F- values (Table 6) did not exceed the tabulated values (t=2.77 
and F=6.39).
Recovery study: The accuracy and precision of the proposed 
method was further ascertained by performing recovery studies. Pre-
analyzed tablet powder was spiked with pure drug at three different 
concentrations and the total was found by the proposed method. Each 
Tablet brand Name* Nominal amount mg per tablet
Found** (% of nominal amount ± SD)
Reference method Proposed Method 
Oxratea 150 mg 99.8 ± 0.80 100.05 ± 1.02t=0.33, F=1.61
Oxetolb 150 mg 99.1 ± 1.10 100.28 ± 0.83t=1.83, F=0.57
Mezalogc 150 mg 99.12 ± 0.66 100.79 ± 1.14t=1.99, F=2.98
*Marketed by, a. Wockhard, b. Sun Pharma, c. La Pharma
**Mean value of five determinations
Tabulated t- and F-values at 95% confidence level are 2.77 and 6.39, respectively.
Table 6: Results of determination of OXC in tablets and statistical comparison with the reference method.
Tablet brand name
Method
OXC tablet solution added, µg ml-1 Pure OXC added, µg ml-1 Total foundµg ml-1 Pure OXC recovered* %  ± SD
Oxrate
5 2.5 7.49 99.78 ± 0.93
5 5 10.04 100.83 ± 1.11
5 7.5 12.47 99.55 ± 1.01
Oxetol
5 2.5 7.49 99.96 ± 0.68 
5 5 10.02 101.04 ± 0.80
5 7.5 12.49 99.84 ± 1.01
Mezalog
5 2.5 7.52 100.83 ± 0.68
5 5 10.06 101.27 ± 1.11
5 7.5 12.52 100.28 ± 1.62
* Mean value of three measurements.
Table 7: Results of recovery experiments via the standard addition technique.
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determination was repeated three times. The recovery of the pure 
drug added was quantitative and revealed that frequently encountered 
common ingredients of tablet formulations were found not to interfere 
with the proposed spectrophotometric method. The results of recovery 
study are compiled in Table 7.
Conclusions
The proposed method for the estimation of OXC was found to 
be simple, sensitive and reliable with good precision and accuracy. 
The method is specific while estimating the commercial formulations 
without interference from any components of pharmaceutical dosage 
forms or degradation products was observed. The behavior of OXC 
under various stress conditions was studied; the degradation of the drug 
under alkaline condition was identified by the change in the absorbance 
values and presented in Figure 3b. i.e., OXC is more sensitive towards 
alkaline conditions and very much resistant towards acidic, oxidative 
and photolytic degradations. The information presented here in could 
be very useful for quality monitoring of bulk samples and as well 
employed to check the quality of drug during stability studies.
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